Clinical Trials Update: Dec. 18, 2007
Claudication Contraception Pancreatic Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
If you are 41 or older, have been diagnosed with peripheral artery disease, and intermittent claudication has been present for six months with no change in the past three, you may be eligible for this study.
The research site is in Chaska, Minn.
If you are a healthy woman 18 to 35, you may qualify for this trial to study the ability of an oral contraceptive to extend length between menstrual periods.
The research site is in Champaign, Ill.
If you are aged 18 to 75 and have diagnosed with pancreatic cancer, you may qualify for this study.
The research site is in Hot Springs, Ark.
Copyright 2007 Thomson CenterWatch. All rights reserved.